Chase Knickerbocker

Stock Analyst at Craig-Hallum

(1.32)
# 1623
Out of 5,240 analysts
32
Total ratings
57.89%
Success rate
12.59%
Average return
15 Stocks
Name Action Price Target Current % Upside Ratings Updated
Eton Pharmaceuticals
Maintains: Strong Buy
15 18
13.39 34.43% 4 Jan 8, 2025
scPharmaceuticals
Maintains: Buy
16 12
3.42 250.88% 2 Nov 14, 2024
KORU Medical Systems
Maintains: Strong Buy
4 5
4.04 23.76% 1 Nov 14, 2024
PolyPid
Initiates Coverage On: Buy
10
3.09 223.62% 1 Nov 4, 2024
Indivior
Maintains: Buy
20 16
11.23 42.48% 3 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
45 65
33.54 93.8% 3 Oct 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 8
n/a n/a 2 Sep 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 15
5.62 166.9% 4 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 10
3.65 173.97% 3 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 12
8.6 39.53% 2 Aug 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
6.12 63.4% 1 Jul 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
12.71 41.62% 1 Jun 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 23
8.03 186.43% 2 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
1 2
0.55 118.18% 2 Jul 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
6.78 209.73% 1 Mar 13, 2023